Following a meeting with the FDA’s Gastrointestinal Drug Advisory Committee Friday, the future of Intercept’s rare liver ...

PH-284 is under clinical development by VistaGen Therapeutics and currently in Phase II for Cachexia. According to GlobalData, Phase II drugs for Cachexia does not have sufficient historical data to ...

The Department of Health (DOH) reiterated that the Food and Drug Administration (FDA) has not approved any mpox vaccine to ...

Renovos Biologics (Renovos), today announces the appointment of Lisa Ferrara, Ph.D., to its Board as a Non-Executive Director.

US FDA approves Roche’s Ocrevus Zunovo to treat relapsing multiple sclerosis and PPMS: Basel Tuesday, September 17, 2024, 10:00 Hrs [IST] Roche announced that the United States ...

The study concentrates on the FDA-approved injectable medications semaglutide and liraglutide. A study conducted by the ...

Tecentriq Hybreza provides patients and physicians with greater flexibility of treatment options while showing safety and efficacy consistent with intravenous(IV) Tecentriq 1,2 New subcutaneous (SC) ...

"Hearing loss is a significant public health issue impacting millions of Americans," explains Michelle Tarver, M.D., Ph.D., acting director of the FDA's Center for Devices and Radiological Health.

Their top candidate was DNP, which has been approved since 1996 to treat Alzheimer ... produced at scale on a much shorter ...

Providers of vaccines against African swine fever (ASF) from four countries are seeking the Food and Drug Administration’s (FDA) approval, according to Agriculture Secretary Francisco Tiu Laurel Jr.

When researchers discovered enough proof that a medication used to treat bone marrow cancer and Kaposi sarcoma is safe and effective in treating hereditary hemorrhagic telangiectasia (HHT), a rare ...